Zhang Xiaomin, Liu Wei, Zhou Yang, Qiu Jinxin, Sun Yanjun, Li Ming, Ding Yiqian, Xi Qinghua
Department of Obstetrics and Gynecology, Nantong Maternal and Child Health Hospital Affiliated to Nantong University, Nantong, China; Department of Obstetrics and Gynecology, Affiliated Hospital of Nantong University, Nantong, China.
Department of Obstetrics and Gynecology, Affiliated Hospital of Nantong University, Nantong, China.
Ann Palliat Med. 2021 Jun;10(6):6804-6823. doi: 10.21037/apm-21-1296.
This research aims to study the efficacy of an integrated approach to prevent and treat the recurrence of intrauterine adhesions (IUA) after hysteroscopic adhesiolysis.
A total of 96 patients diagnosed with moderate-to-severe intrauterine adhesions (IUA) in Nantong Maternal and Child Health Hospital from January 2016 to December 2019 were included in this parallel, randomized and single-center trial. Moderate (48 cases) and severe (48 cases) patients were randomly divided into three groups by a computer random generator: Group A (IUD, n=16), Group B, (Foley1w+IUD, n=16) and Group C (Foley1m+IUD, n=16). All patients received sequential treatment of estrogen and progesterone on the day of operation. Follow-up was performed at 1 and 3 months after treatment of uterine cavity, endometrial thickness, menstruation and pregnancy. Surgeons who performed the second-look and third-look hysteroscopy and postsurgical assessors were blinded to the randomization.
In total, 96 patients (48 cases in each degree) were included in the final analysis, with 16 cases in each group. No cases were lost to follow up. The primary outcome measure was AFS score, which was significantly lower in Group C than that of women in group A and Group B at 1 month (P<0.05). Similar results were observed at 3-month follow up. In patients with moderate adhesions, the pregnancy rate in Group C (Foley1m+IUD) was higher than that in Group A and Group B (P<0.05). However, in patients with severe adhesions, there was no significant difference in the pregnancy rate among the three groups (P>0.05). There was no statistical significance in infection indicators among the three groups of moderate and severe patients (P>0.05). Postoperative complications such as uterine perforation, severe bleeding, water poisoning and intrauterine infection were not observed.
The effect of a Foley intrauterine balloon combined with IUD in preventing re-adhesion was better than that of an IUD alone. For patients with moderate adhesion, the prolongation of placement time could prevent intrauterine re-adhesion and significantly improve the pregnancy rate with strong safety. However, for patients with severe adhesions, the prolongation of intrauterine Foley balloon placement did not better prevent intrauterine re-adhesions, improve menstruation, or improve pregnancy rates.
Chinese Clinical Trial Registry ChiCTR2100046945.
本研究旨在探讨综合治疗方法预防和治疗宫腔镜粘连松解术后宫腔粘连(IUA)复发的疗效。
本平行、随机、单中心试验纳入了2016年1月至2019年12月在南通妇幼保健院诊断为中重度宫腔粘连(IUA)的96例患者。将中度(48例)和重度(48例)患者通过计算机随机生成器随机分为三组:A组(宫内节育器,n = 16)、B组(Foley球囊1周+宫内节育器,n = 16)和C组(Foley球囊1个月+宫内节育器,n = 16)。所有患者在手术当天接受雌激素和孕激素序贯治疗。在治疗后1个月和3个月对宫腔、子宫内膜厚度、月经和妊娠情况进行随访。进行二次和三次宫腔镜检查的外科医生以及术后评估人员对随机分组情况不知情。
最终分析共纳入96例患者(各程度48例),每组16例。无失访病例。主要观察指标为美国生育学会(AFS)评分,C组在1个月时的AFS评分显著低于A组和B组女性(P<0.05)。在3个月随访时观察到类似结果。在中度粘连患者中,C组(Foley球囊1个月+宫内节育器)的妊娠率高于A组和B组(P<0.05)。然而,在重度粘连患者中,三组间妊娠率无显著差异(P>0.05)。三组中重度患者的感染指标无统计学意义(P>0.05)。未观察到子宫穿孔、严重出血(大出血)、水中毒和宫内感染等术后并发症。
Foley宫内球囊联合宫内节育器预防再粘连的效果优于单纯宫内节育器。对于中度粘连患者,延长放置时间可预防宫腔再粘连,并显著提高妊娠率,安全性高。然而,对于重度粘连患者,延长宫内Foley球囊放置时间并不能更好地预防宫腔再粘连、改善月经或提高妊娠率。
中国临床试验注册中心ChiCTR2100046945